THERAPEUTIC AREAS CARDIOVASCULAR RESEARCH
|
|
- Horatio Walters
- 5 years ago
- Views:
Transcription
1 THERAPEUTIC AREAS CARDIOVASCULAR RESEARCH
2 PPD S CARDIOVASCULAR TEAM: OPTIMIZING TRIALS AND IMPROVING OUTCOMES
3 APPLYING EXPERIENCE, INNOVATION AND EFFICIENCY IN THE FIGHT AGAINST CARDIOVASCULAR DISEASE PPD has extensive experience in planning and implementing Phase I IV programs for cardiovascular drug development, ranging from single-site dose exploration studies to multinational outcomes studies with hundreds of sites and thousands of patients. MEETING THE NEEDS OF TODAY S CLINICAL TRIAL CHALLENGES Cardiovascular clinical trials are now larger and more complex than ever, presenting significant challenges in terms of time and cost. These studies often require both a global approach and deep medical and operational expertise in order to prove the therapeutic benefit of new treatments. As an experienced partner with cardiovascular expertise, operational capacity and global resources, PPD can provide the insight and access to help you develop an effective study protocol, overcome challenges and manage complex cardiovascular trials, regardless of size or scope. HELPING YOU EXPLORE NEW STRATEGIES FOR SUCCESS PPD employs a highly consultative approach to understand fully the needs of your cardiovascular program. We apply broad strategic development expertise in cardiovascular research, significant global access and vetted feasibility processes to help you gain efficiencies by selecting the best countries and sites and the most suitable patient populations. Furthermore, we align your study protocol with marketing plans to ultimately help you realize your product s greatest value. As a leader in cardiovascular research, PPD provides you with: + + Comprehensive cardiovascular experience, with more than 100 trials conducted in the past five years + + Extensive cardiovascular outcomes experience and expertise + + A global team of nearly 1,900 scientific and operational experts led by cardiovascular physicians, as well as a global network of more than 5,000 experienced cardiovascular investigators + + Imaging solutions through our partnership with VirtualScopics, Inc.
4 COMPREHENSIVE EXPERIENCE THAT SPANS THE DEVELOPMENT PROCESS AND THE GLOBE
5 PPD combines extensive experience and a global presence to optimize cardiovascular product development programs from early phase through post-approval. CARDIOVASCULAR TRIAL EXPERIENCE (Past Five Years) CARDIOVASCULAR OUTCOMES RESEARCH EXPERIENCE Cardiovascular outcomes research comes with significant risk in terms of cost and time delays to market. Our medical and operational experts can help you strategically design trials from single studies to full clinical programs, while our therapeutically aligned medical safety, scientific, project management and regulatory experts provide strategic planning, support and execution oversight at every stage to preserve efficiency, diminish risks and assure that program objectives are met. + + Standard MedDRA queries specific for major adverse cardiac events (MACE) to ensure that no potential cardiovascular event is missed Phase I 6 Phase II 25 Phase III 51 Phase IV/Post-Approval 13 No Phase/Other Cardiovascular outcomes working group led by experienced cardiologists and clinical scientists with in-depth experience in Type 2 diabetes and other disorders that carry cardiovascular risks + + Industry-leading analytics tool, which provides custom guidance and highlights potential risks + + Experience with various academic research organization (ARO) partnership models Our comprehensive product development experience includes: + + In-depth experience with key cardiovascular indications, such as acute coronary syndrome, lipid disorders, heart failure, venous thromboembolism and arrhythmias + + Significant cardiovascular stem cell research experience + + Development of device and drug-device products PPD has conducted 11 cardiovascular outcomes studies in the past five years, involving more than 83,000 patients and 8,100 sites. Our experience includes cardiovascular outcomes research in support of therapies developed to treat key indications, such as: + + Type 2 diabetes + + Acute coronary syndrome + + Hyperlipidemia/dyslipidemia + + Obesity
6 AN INTEGRATED APPROACH GUIDES PROGRAMS THROUGH DRUG DISCOVERY AND DEVELOPMENT PPD s worldwide team of experts includes physicians, project managers, clinical team managers and clinical research associates who have broad medical expertise and cardiovascular specialization. PPD Locations Backed by the resources of a leading global CRO, these experts apply their therapeutic experience, in-depth understanding of current standards of clinical practice and state-of-the-art approaches to plan and execute your cardiovascular study. PPD can help you anticipate and proactively overcome clinical and regulatory challenges across all areas of product development. This expertise saves valuable time and speeds informed go/no-go decision-making.
7 CARDIOVASCULAR PROJECT TEAM PPD employs more than 1,900 professionals globally with experience conducting a broad range of cardiovascular studies. + + Led by experienced cardiovascular physicians who provide strategic guidance or protocol development and execution + + Cross-functional project teams work efficiently to meet project timelines and achieve the highest quality standards within budget + + Continuity in project teams and strong succession planning support your cardiovascular project throughout its entire life cycle, from strategy and feasibility, to study design and monitoring, to data analysis and reporting INTERNATIONAL INVESTIGATOR NETWORK Achieving success in large, multi-national cardiovascular trials requires far-reaching clinical and operational resources. PPD has the expertise and resources to meet your needs through: + + A worldwide investigator network that includes more than 5,000 cardiologists with diverse specialties and experience in cardiovascular clinical trials + + Extensive relationships with global study sites that enable efficient subject recruitment to help you reach target enrollments that represent patient populations and match study protocol requirements
8 CARDIOVASCULAR-FOCUSED SERVICES THAT ASSURE QUALITY AND PRECISION
9 PPD offers a full spectrum of cardiovascular-focused services as part of a comprehensive clinical trial solution. PHARMACOVIGILANCE + + Experience in more than 30 global trials that have adjudicated clinical endpoints + + Access to a robust electronic adjudication system, which allows for remote event adjudication in real time + + Dedicated adjudication group for clinical endpoint and committee management + + Physicians and health care professionals around the world experienced in all aspects of drug development and drug safety and with extensive expertise across leading cardiovascular indications + + More than 400 highly skilled medical and safety professionals with first-hand knowledge of regulatory requirements and therapeutic experience, providing safety coverage 24 hours per day, seven days per week CLINICAL DATA MANAGEMENT + + Extensive data management experience for Phase I IV clinical cardiovascular trials + + Global clinical data management staff with the knowledge to address local needs and the global reach to manage large, multi-national trials + + Data management specialists actively involved from study start-up to database lock to ensure trials are closed quickly and with the highest level of quality BIOSTATISTICS + + Accelerated decision-making through adaptive trial design, real-time analysis, and innovative, integrated technology and statistical solutions + + Comprehensive analysis plans tailored to meet the needs of your project and optimize efficiencies throughout all phases, from initial dose titration through post-approval REGULATORY AFFAIRS + + Constant monitoring of the global regulatory environment related to cardiovascular products to enable better navigation of the regulatory process from preparation to submission + + Long-standing relationships with the U.S. Food & Drug Administration (FDA), European Medicines Agency (EMA) and national agencies help ensure timelines are met so you can get your product to market faster + + Global regulatory strategy development, supported by regulatory staff across North America, Europe, Latin America and Asia Pacific, provides expertise across a wide range of products LATE STAGE RESEARCH + + More than 10 years experience developing and implementing late stage research, including patient registries and observational studies + + Comprehensive management that ensures long-term product value and market support Industry-leading endpoint-driven cardiovascular imaging capabilities through our partnership with VirtualScopics, Inc. + + Global standardization of imaging acquisition study and data collection for large and complex trials + + Standardized data transfers with rolling reconciliation + + Streamlined vendor management + + Full spectrum of cardiovascular clinical and medical imaging services + + Superior data quality via meticulous documentation, global audits and independent, senior-level review
10 DISCOVERY AND LABORATORY SERVICES THAT PROVIDE INSIGHT AND VALUE
11 From single-protocol studies to full compound development programs, PPD has the scientific expertise to help you successfully and swiftly make critical decisions for your cardiovascular discovery and development programs. CENTRAL LABORATORIES Strategically located in Belgium, China, Singapore and the United States, our laboratory facilities: + + Follow global standard operating procedures (SOPs) and conduct weekly cross-validation of results among PPD facilities to ensure consistency and provide globally comparable and combinable data throughout each study + + Provide integrated central laboratory services, including biomarker measurement services, to investigator sites in virtually every country of the world an important consideration when conducting a multi-national trial + + Use a single, fully integrated, web-based database with no need to merge or harmonize data + + Utilize PPD Clicks technology a secure website to view and analyze the most current lab results + + Integrate CRO and central lab data through a proprietary, automated platform DISCOVERY SERVICES + + End-to-end integrated services, from lead generation to pre-clinical candidacy to sponsorship + + Resources include BioDuro, A PPD Company, a state-of-the-art, fully integrated life science research service provider, with a combined 180,000 square feet of laboratory space in Beijing and Shanghai and more than 600 researchers BIOANALYTICAL LABS + + Our bioanalytical laboratories in Richmond, Va., and Madison, Wis., provide comprehensive, state-of-theart assay development, transfer, validation and sample analysis capabilities with extensive experience in cardiovascular compounds cgmp LABS + + PPD has been extensively involved in supporting the analysis of stents, stability and release testing from Phase II to market + + Uniquely positioned to support your cardiovascular research, PPD s central labs have:»» More than 25 years of experience in lipids/ cardiovascular testing»» Provided unique HMG-CoA inhibition testing for every statin released to market»» An extensive menu of cardiac biomarkers»» A comprehensive offering of related renal, diabetes, inflammatory and hormonal biomarkers
12 For more information, please contact us at , or at Pharmaceutical Product Development, LLC. All rights reserved.
PPD LABORATORIES COMPREHENSIVE SERVICES
PPD LABORATORIES COMPREHENSIVE SERVICES PPD_Comprehensive_Brochure2016_SinglePages_FINAL.indd 1 6/9/2016 6:04:02 PM PPD LABORATORIES: GLOBAL INNOVATIVE PROVEN PPD Laboratories combines world-class scientific
More informationAT A GLANCE. inventivhealthclinical.com
AT A GLANCE inventivhealthclinical.com 1 Table of Contents OVERVIEW 02 PHASE I-IIA 03 PHASE IIB-III 04 LATE STAGE 05 STRATEGIC RESOURCING 06 BIOANALYTICAL 07 QUALITY ASSURANCE 08 CONSULTING 09 THERAPEUTIC
More informationHELPING DELIVER LIFE-CHANGING THERAPIES HEMATOLOGY ONCOLOGY
HELPING DELIVER LIFE-CHANGING THERAPIES HEMATOLOGY ONCOLOGY PROVIDING COMPREHENSIVE SOLUTIONS IN A COMPLEX ENVIRONMENT PPD IS A PARTNER WITH PROVEN CAPABILITIES THAT SUPPORT AND ADVANCE ONCOLOGY RESEARCH
More informationPharmaceutical Product Development NASDAQ: PPDI. Dan Darazsdi Chief Financial Officer. Credit Suisse Healthcare Conference November 2009
Pharmaceutical Product Development NASDAQ: PPDI Dan Darazsdi Chief Financial Officer Credit Suisse Healthcare Conference 2009 12 November 2009 Safe Harbor Except for historical information, all of the
More informationCLINICAL DEVELOPMENT SERVICES. Immune-Mediated Inflammatory Diseases
CLINICAL DEVELOPMENT SERVICES Immune-Mediated Inflammary Diseases Table of contents 01 The new inflammation paradigm 02 Solutions for your success 03 An interconnected perspective 04 High-quality data
More informationWelcome. Thank you for joining us. Irina Moissiu, Director Client Relations Laurie Furiness, EVP Operations & Consulting Services
Welcome Thank you for joining us Irina Moissiu, Director Client Relations Laurie Furiness, EVP Operations & Consulting Services 360 o SERVICE PERFORMANCE MEASUREMENT Sponsor View TM 5 Assessments Available
More informationThis is Julius Clinical
This is Julius Clinical WE ARE THE RESEARCH ORGANISATION THAT IS ABLE TO COMBINE THE LATEST SCIENTIFIC INSIGHTS WITH OPERATIONAL EXCELLENCE TO FIND CREDIBLE, CREATIVE, COST-EFFECTIVE SOLUTIONS FOR CLINICAL
More informationWHITE PAPER. establishing a regulatory Drug Development Strategy for Asia Pacific
WHITE PAPER establishing a regulatory Drug Development Strategy for Asia Pacific ppdi.com July 2012 EXECUTIVE SUMMARY As the economic power of China and other Asian countries grows, many biopharmaceutical
More informationThe In Vitro Diagnostic CRO
The In Vitro Diagnostic CRO Choose Beaufort Because of Our People, Processes and Proven Experience The value of expertise cannot be overstated, especially when it comes to streamlining complicated in vitro
More informationYour bridge to. better medicines
Your bridge to better medicines At a Glance Anapharm Bioanalytics is a client-oriented, GLP-certified, FDA-inspected, GCP-compliant and ANVISA-certified bioanalytical contract research organization (CRO)
More informationecoa SOLUTIONS Eliminate ecoa complexity so you can move ahead quickly
ecoa SOLUTIONS Eliminate ecoa complexity so you can move ahead quickly THE PROBLEM WITH COA The quality of collected patient data, study timelines and study costs are influenced by a number of factors,
More informationTrial Services. The allround trial specialist in cardiology Leading since cardialysis.com
Trial Services The allround trial specialist in cardiology Leading since 1983 cardialysis.com Trial design The key factor in achieving a successful clinical trial is to have a well-prepared, consistent
More informationCENTRAL LABORATORY SERVICES. Immune-Mediated Inflammatory Diseases
CENTRAL LABORATORY SERVICES Immune-Mediated Inflammatory Diseases Table of contents 01 Accelerating drug development starts here 02 Experience inspires innovation 03 Powerful results depend on reliable
More informationBIOPHARMA SOLUTIONS TM Expedite Your Drug Development Program
BIOPHARMA SOLUTIONS TM Expedite Your Drug Program Maximize the Value of Your Asset The journey of drug development can be complex stressful. But it doesn t have to be that way. Join more than 600 biopharmaceutical
More informationFRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up?
FRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up? The following framework of characteristics focuses on attributes that are within the control of investigators and their
More informationDepartment At-A-Glance
Integrated Site Services Functional Role Integrated Site Services (ISS) includes global and country Start-Up and Regulatory units (RSU) and Integrated Patients & Site Services (IPSS). Our department s
More informationPAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey
PAREXEL GENOMIC MEDICINE SERVICES Applying genomics to enhance your drug development journey YOUR JOURNEY. OUR MISSION. Genomic expertise to simplify the route to product approval and maximize patient
More informationCentral Laboratory Services. Anatomic Pathology Histology Services
Central Laboratory Services Anatomic Pathology Histology Services Oncology and Beyond... There is no question that innovations in technology have the potential to significantly impact a number of clinical
More informationAsia A New Frontier for Clinical Research and Development
Asia A New Frontier for Clinical Research and Development Executive Summary As the pharmaceutical market experiences rapid growth in Asia, more clinical trials are being conducted in the region, offering
More informationA Streamlined Data Capture and Exchange Partnership that Delivers Faster Decisions
A Streamlined Data Capture and Exchange Partnership that Delivers Faster Decisions 2011 SAS Health & Life Sciences Conference Michelle Combs, PhD, VP, Clinical Pharmacology Sciences, Celerion Bernd Doetzkies,
More informationEnabling faster insights to improve clinical trial efficiency and quality
Enabling faster insights to improve clinical trial efficiency and quality Clarity, understanding and confidence Every clinical trial has moments when decisive action is needed to set the course for a
More informationSTARTING STRONGER IN PHASE I THROUGH IIA
PAREXEL CLINICAL RESEARCH SERVICES: EARLY PHASE STARTING STRONGER IN PHASE I THROUGH IIA Adding value from first-in-human through proof-of-concept YOUR JOURNEY. OUR MISSION. Achieve success through early
More informationMCRA Clinical More Than Your Average CRO. Clinical Project Management. Site Management and Study Monitoring. Data Management. Auxiliary Services
MCRA s unique Clinical Research Organization (CRO) enables international and US-based orthopedic companies of all sizes to successfully execute a clinical study. Our philosophy is to streamline the clinical
More informationOCTC 2012 CRO Selection
OCTC 2012 CRO Selection Colin Macaulay Viron Therapeutics Inc. 15 Nov 2012 Viron Therapeutics Inc. Virtual Biotech Company (6) Phase 2a (48 pt) clinical trial in acute coronary syndrome (ACS) completed
More informationProof of Concept. Achieve your molecule s full potential
Proof of Concept Achieve your molecule s full potential Table of contents 01 Maximize the value of your molecule 02 Enhance your resources and 03 Increase your speed and efficiency 04 your product s market
More informationMANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners
MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical
More informationin full-service contract pharmaceutical development and manufacturing
in full-service contract pharmaceutical development and manufacturing THE Norwich Advantage Norwich is a recognized leader in full service contract pharmaceutical development and manufacturing. As a single-source
More informationGLOBAL TRENDS SURVEY REPORT
GLOBAL TRENDS SURVEY REPORT + OVERVIEW Clinical trials have become increasingly global in scope. Some countries require testing of drugs in a country before they can be approved for sale in that country.
More informationPartnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC To Our Potential Partners We offer partners the depth of
More informationThe Promise and Challenge of Adaptive Design in Oncology Trials
THE POWER OFx Experts. Experience. Execution. The Promise and Challenge of Adaptive Design in Oncology Trials Clinical oncology trials are more complex and time consuming than those in any other therapeutic
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7
More informationImprove your probability. of success
Improve your probability of success FROM PIPELINE TO PORTFOLIO TO POPULATION HEALTH TM Creating a healthier world will require the industry s best thinking and resources. It will also demand working together
More informationPAREXEL ACCESS MANAGED ACCESS PROGRAMS
PAREXEL ACCESS MANAGED ACCESS PROGRAMS Demands are increasing on biopharmaceutical companies developing treatments for unmet diseases to make them available to select patients even before the drug is labeled,
More informationCorporate Presentation. October 2017
Corporate Presentation October 2017 Company Overview OPIS is an international CRO providing: - A wide range of clinical and e-clinical services for Pharmaceutical and Biotechnology Industries, Medical
More informationLeading Provider of Technology-Enabled Solutions for Clinical Research
Leading Provider of Technology-Enabled Solutions for Clinical Research SUCCESSFUL CLINICAL TRIALS REQUIRE THE ABILITY TO SEE KEY DETAILS AND UNCOVER HIDDEN INSIGHTS. utilizes science and technology to
More informationMANAGING MATURE PRODUCT PORTFOLIOS - KEY CHALLENGES AND BENEFITS
WHITEPAPER MANAGING MATURE PRODUCT PORTFOLIOS - KEY CHALLENGES AND BENEFITS Dr. Constanze Burkhardt Senior Director, Strategic Outsourcing constanze.burkhardt@pharmalex.com Constanze has worked for PharmaLex
More informationTailoring best practices for the evaluation of endpoints in clinical device trials
Tailoring best practices for the evaluation of endpoints in clinical device trials George Dangas, MD, PhD Cardiac Safety Research Consortium 11 th March, 2016 ROADMAP Study blinding challenges Variability
More informationMOSAIQUES DIAGNOSTICS
MOSAIQUES DIAGNOSTICS CLINICAL PROTEOMICS IN DRUG DEVELOPMENT INFORMATION Clinical Proteomics for early and differential diagnosis FDA Letter of Support Possibilities of a companion test in Drug Development
More informationReducing the Time to Market with an eclinical System
Reducing the Time to Market with an eclinical System Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective owners. Copyright
More informationSTRATEGIC RESOURCING. inventivhealthclinical.com
STRATEGIC RESOURCING inventivhealthclinical.com 1 Table of Contents OVERVIEW 02 STAFFING 03 MOVING UP THE VALUE CHAIN 04 FUNCTIONAL EXPERTISE Biostatistics and Statistical Programming 05 Clinical Monitoring
More informationCurrent State of Endpoint Adjudication in Device Trials Academic View
HARVARD MEDICAL SCHOOL Current State of Endpoint Adjudication in Device Trials Academic View CSRC/MDEpiNet Device Adjudication March 11, 2016 Donald E. Cutlip, MD Harvard Clinical Research Institute Smith
More information1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and
1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and Development Market in Asia - Overview 3.1 Introduction 3.1.1
More informationClinical Data Management Services
Clinsoft Overview Clinical Trial Management Clinical Data Management Services Medical Writing & Pharmacovigilance Services 2 Overview Started in 2008 with a small group of 7 team members. Expanded to a
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8
More informationTHE BIOSIMILARS LANDSCAPE: STRATEGIES FOR CLINICAL AND COMMERCIAL SUCCESS
THE BIOSIMILARS LANDSCAPE: STRATEGIES FOR CLINICAL AND COMMERCIAL SUCCESS What all developers need to know Alicia Baker Director, Global Regulatory Affairs Strategy, Covance John Carlsen, MHA Vice President,
More informationCell Therapy Services Your Product. Our Passion.
Pharma&Biotech Cell Therapy Services Your Product. Our Passion. Complete Portfolio of Services for cgmp Manufacturing of Cell-based Products Pharma&Biotech Cell Therapy Services for cgmp Manufacturing
More informationMDI Manufacturing Services
MDI Manufacturing Services Presenter, Date Who we are 3M Drug Delivery Systems is a division of 3M dedicated to working together with pharmaceutical and biotech companies to bring new and improved products
More informationEstablishment of Clinical Trial Infrastructure
Taiwan s Strategy in the Establishment of Clinical Trial Infrastructure Chei-Hsiang Chen, Ph. D. Director, Biotechnology and Pharmaceutical Industries Program Office, Ministry of Economic Affairs, Taiwan
More informationCRO partner in Rx/CDx Co-Development
CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics
More informationSMARTER DRUG DEVELOPMENT: TRANSFORMING YOUR CLINICAL OPERATING MODEL
SMARTER DRUG DEVELOPMENT: TRANSFORMING YOUR CLINICAL OPERATING MODEL Perspective WHY NOW? THE URGENCY TO CHANGE THE CLINICAL OPERATING MODEL While today is an exciting time for the biopharma industry in
More informationGxP Auditing, Remediation, and Quality System Resourcing
GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing
More informationThe Role of the CRO in Effective Risk-Based Monitoring
New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging
More informationRisk-Based Monitoring Improves Site Performance and Investigator Satisfaction
Insight brief Risk-Based Monitoring Improves Site Performance and Investigator Satisfaction By reading this insight brief, you ll learn how RBM: Leads to earlier insights that improve trial quality Influences
More informationExplore the World of End-to-End. Integrated Lab Performance
Explore the World of End-to-End Integrated Lab Performance Come explore the largest, wholly owned network of BioPharma dedicated laboratories in the world. Discovery/Pharmacology Pre-Clinical/Early Development
More informationOptimizing Clinical Research Operations with Business Analytics
WHITE PAPER Optimizing Clinical Research Operations with Business Analytics Improving clinical research with analytics Table of Contents The Proven Standard for Clinical Data Analysis...1 Why Clinical
More informationGetting Connected: The Benefits of a Unified Clinical Platform
WHITE PAPER Getting Connected: The Benefits of a Unified Clinical Platform December 2017 Table of Contents 01 Getting Connected: The Benefits of a Unified Clinical Platform 05 New Technologies 04 Changing
More informationESTERN Medical See more, do more and expect even more
ESTERN Medical See more, do more and expect even more 1 ESTERN Medical is the CRO of choice for radiological imaging studies in Latin America. 2 Broad Radiological Trials Experience ESTERN Medical personnel
More informationMulti-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes
WHITE PAPER Multi-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes Author: SCOTT SCHLIEBNER Vice President, Rare Disease - Scientific Affairs
More informationArtificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle
Volume XX, Issue 60 Artificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle Artificial intelligence (AI) has the potential to transform the pharmaceutical industry.
More informationEmerging Trends in Regulatory Outsourcing WHITE PAPER.
WHITE PAPER www.makrocare.com/consulting You are not alone in the quest for bringing your products to market and improve the quality of the life for millions! MakroCare brings you the insight on how a
More informationEARLY PHASE DEVELOPMENT SOLUTIONS
EARLY PHASE DEVELOPMENT SOLUTIONS Real-world case studies demonstrating accelerated timelines, risk reduction and measurable cost savings are possible Early Phase Development Solutions is a unique drug
More informationIntroducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration
Introducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration 1 2 Translational Informatics Overview Precision s suite of services is
More informationBelgium, a European leader in clinical trials
Belgium, a European leader in clinical trials An attractive country for clinical trials to test innovative medicines In Europe it is nearly impossible to find other countries with as many clinical trials
More informationInnovative Medicines Initiative
Innovative Medicines Initiative EMA - EBE Regulatory Conference on ATMPs Salah-Dine Chibout, Novartis Global Head Discovery & Investigative Safety/ Global Head Preclinical Safety Therapeutic Areas IMI
More informationNUVISAN GROUP. Our Philosophy
NUVISAN GROUP Our Philosophy 2 EARLY DEVELOPMENT Introduction to Nuvisan Fully integrated Contract Research Organisation headquarted in Neu-Ulm, southern part of Germany. Nuvisan - Early Development Headquartered
More informationA drug development crossroad lies ahead
G L O B A L C B O C O S T E F F E C T I V E B I O A N A L Y T I C A L H I G H Q U A L I T Y E A R L Y S T A G E C L I N I C A L T R A N S L A T I O N A L M E D I C I N E H I G H L Y C O M P E T E N T A
More informationWe ll help you create the products that build a better world.
We ll help you create the products that build a better world. At Plexus, we re excited about what you do. Because we believe in why you do it. Every idea starts with a purpose. Our specialty is bringing
More informationInnovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing
Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Overview Serving biotech and pharma community since 1998 Proven track record of advancing small molecules from
More information3M Drug Delivery Systems. April 26, 2011
3M MDI Manufacturing April 26, 2011 3M Drug Delivery Systems Drug Delivery Systems Overview 3M Drug Delivery Systems is a division of 3M that is dedicated to the development and manufacturing of inhalation
More informationDeveloping Strong Partnerships to Ensure Success With Global Medical Device Trials. 23-February-2017, OCT Burlingame
Developing Strong Partnerships to Ensure Success With Global Medical Device Trials 23-February-2017, OCT Burlingame www.genae.com With you, for you Agenda 01 02 Identify the core group of stakeholders
More informationHUMAN CHALLENGE TESTING
HUMAN CHALLENGE TESTING CLINICAL RESEARCH SOLUTIONS DE-RISKING Faced with increasing pressures on timelines and budgets, clinical research practices need to continuously evolve in order to ensure pipeline
More informationYour Complete Quality Solution Provider for the Life Science Industry
Your Complete Quality Solution Provider for the Life Science Industry PQE at-a-glance Our broad services portfolio, extensive experience, effective project management, and exceptional cost effectiveness,
More informationSAMPLE. Coronary Guidewires - Pipeline Review, Reference Code: GDME0038EPD. Publication Date: June 2015
Publication Date: June 2015 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures... 3 2 Introduction... 5 2.1 Coronary Guidewires Overview... 5 3 Products under
More informationBIOMETRICS SERVICES ADVISORY DATA OFFICE UNBLINDING SECURE INDEPENDENT TEAM PROGRAM. ADaM TRAINER SAFETY SDTM COMPLIANT TA-EXPERTISE SDTM DATA
BIOMETRICS SERVICES DELIVER UNBLINDED DATASETS TO IDMC SDTM-IG UNBLINDING ADVISORY QUALITY ON TIME DEDICATED DATA SECURE BOARD EMERGENCY PARTNERSHIPTEAM DATA OFFICE UNBLINDING INVESTINGEXPERTISE SHARING
More informationPAREXEL STRATEGIC PARTNERSHIPS. Optimizing relationships for shorter time to market
PAREXEL STRATEGIC PARTNERSHIPS Optimizing relationships for shorter time to market YOUR JOURNEY. OUR MISSION. Delivering a more collaborative and operationally efficient relationship so you can reach your
More informationWe set things in motion and keep them moving. Metronomia Clinical Research Services
We set things in motion and keep them moving Metronomia Clinical Research Services Our customers love the fact that we keep up with their individual tempos. Dorothea Wessiepe, Director Biostatistics Metronomia:
More informationRegulatory Requirements for Medical Devices in China
Regulatory Requirements for Medical Devices in China Syneos Health TM 2018 Syneos Health. All rights reserved. How to Register a Foreign Medical Device in China Classification Class 1 Class 2 Class 3 Authority
More informationIndustry Academic Collaboration: A Key to Successful Involvement of Patients Early in Clinical Development
Industry Academic Collaboration: A Key to Successful Involvement of Patients Early in Clinical Development Aernout van Haarst PhD Director, European Corporate Development Feb 2016 Industry Academic Collaboration
More informationCONTRACT RESEARCH SERVICES
1537 NW 65th Avenue Plantation, FL 33313 USA Phone: (954) 321-8988 Fax: (954) 321-9778 info@receptopharm.com www.receptopharm.com ReceptoPharm has installed the pathways to develop, produce and supply
More informationBIOCLINICA CLINICAL DATA MANAGEMENT
BIOCLINICA CLINICAL DATA MANAGEMENT Achieve faster speed to market, with Bioclinica s best-in-class Electronic Data Capture (EDC) technology and in-house full-service Data Management (DM) services. $ BIOCLINICA
More informationENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL
Shaping the Future of Drug Development ENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL Jim Baker Senior Vice President Clinical Research Services Cytel JIM BAKER Senior
More informationAbout Clinical Trials: What They Can Mean For You?
About Clinical Trials: What They Can Mean For You? Karl Cremer, PharmD and AnnKatrin Petersen, MD, MS January 25, 2012 ClinicalStudy.org Owned and operated by PRI, Inc. 5927 Balfour Court, Suite 201 Carlsbad,
More informationPutting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay
How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay Jon Roth, Vice President, Data Sciences & Biometrics Authorized Trainer for ADaM, CDISC Mark Vieder,
More informationEXPERT ISE YOU CAN TRUST
EXPERT ISE YOU CAN TRUST 03 Contents INTRODUCTION 04 THIS IS WHO WE ARE 06 THIS IS WHAT WE DO 08 OUR SERVICES 10 Regulatory Strategy Services 12 Product Registrations & Maintenance 13 Electronic Publishing
More informationPharmaceutical Product Development NASDAQ: PPDI Fred Eshelman Chief Executive Officer
Pharmaceutical Product Development NASDAQ: PPDI Fred Eshelman Chief Executive Officer Banc of America Healthcare Conference 2008 13 May 2008 Safe Harbor Except for historical information, all of the statements,
More informationPharmaceutical Product Development NASDAQ: PPDI Fred Eshelman Chief Executive Officer
Pharmaceutical Product Development NASDAQ: PPDI Fred Eshelman Chief Executive Officer R.W. Baird Growth Stock Conference 2008 14 May 2008 Safe Harbor Except for historical information, all of the statements,
More informationInnovations in Clinical
Innovations in Clinical Accelerating Insights & Data-Driven Decisions Masha Hoffey Director, Clinical Analytics 15 September 2016 HUMAN HEALTH ENVIRONMENTAL HEALTH 2014 PerkinElmer Contents Introduction
More informationBEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM
BEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM Six steps to ensuring risk-based quality management in clinical trials EVOLVING REGULATIONS ON RISK-BASED MONITORING In 2016, the International
More informationPrecision Biospecimen Solutions: Paving the Way to Personalized Medicine
Precision Biospecimen Solutions: Paving the Way to Personalized Medicine ACCELERATING RESEARCH. IMPROVING OUTCOMES. The companies under the Precision for Medicine banner deliver specialized strategic and
More informationSustaining long-term growth by focusing on our customers
Strategy in action Sustaining long-term growth by focusing on our customers Our capabilities and customer focused strategy are opening growth opportunities in addressable markets of approximately $8 billion.
More informationADB Consulting & CRO Inc.
DATA MANAGEMENT, BIO-STATISTICS, CLINICAL OPERATIONS, QUALITY SYSTEMS & STAFFING SERVICES Abbreviated Edition December 2005 Advancing Data Management, Bio-statistics, Clinical Operations, & Quality Systems
More informationINTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES
WHITE PAPER INTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES Randomization is fundamental to clinical trials it enables treatment group balance, eliminates selection bias and limits
More informationOverview and Frequently Asked Questions
Overview and Frequently Asked Questions Overview Oracle Buys Relsys: Adds advanced drug safety and risk management applications to extend Oracle s leadership in health sciences Oracle has acquired Relsys
More informationDEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE WHEN COMMERCIALIZING A MEDICINE, IT
More informationMEDICAL DEVICES STUDIES
AN OVERVIEW OF MEDICAL DEVICES STUDIES Outsourcing Trends & Regulatory Landscape in Europe and Latin America - whitepaper - MARKET & LANDSCAPE At Eurotrials, we work to deliver a best in class solution
More informationRisk-Based Monitoring: How Can It Be Implemented For More Effective Study Oversight
Risk-Based Monitoring: How Can It Be Implemented For More Effective Study Oversight Lisa Marie Saldanha Senior Director & Head of Operations Real World Insights Asia Singapore Research & Ethics Conference
More informationCOUNT ON US FROM NON-STERILE TO STERILE FROM GELS AND CREAMS TO OINTMENTS AND AEROSOLS FROM CONCEPT TO COMMERCIALIZATION FROM VIRTUAL TO LARGE PHARMA
COUNT ON US FROM NON-STERILE TO STERILE FROM GELS AND CREAMS TO OINTMENTS AND AEROSOLS FROM CONCEPT TO COMMERCIALIZATION FROM VIRTUAL TO LARGE PHARMA WHO WE ARE DPT is a Contract Development and Manufacturing
More informationIMARC Research, Inc. Executive Summary. Independent. Monitoring. Auditing. Research. Consulting WE LL EARN YOUR APPROVAL.
IMARC Research, Inc. Executive Summary Independent Monitoring Auditing Research Consulting WE LL EARN YOUR APPROVAL. Introduction IMARC Research was founded in 1999 by Harold and Sandy Maddock who both
More informationMedical Outcome Trials: Trends, Design Approaches and Operational Strategies for Success
Medical Outcome Trials: Trends, Design Approaches and Operational Strategies for Success Good Research Practice (GRP) Webinar Philip Galtry Patricia Steigerwald, MS, RN Copyright 2014 Quintiles Your Presenters
More information